Načítá se...
T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA
BACKGROUND: Xanomeline is a M1 /M4 preferring muscarinic agonist that has demonstrated antipsychotic and pro-cognitive effects in both schizophrenia (Shekar, et al, 2008) and Alzheimer’s disease (Bodick et al, 1997). However, its peripheral cholinergic side effects, including nausea, vomiting and di...
Uloženo v:
| Vydáno v: | Schizophr Bull |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455874/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz019.386 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|